Victoria M. Ho, MD, PhD

Dr. Rosen received her BA from Rice University and her medical degree from Baylor College of Medicine in Houston. She completed her Pediatric Residency at UCLA School of Medicine.For the first fifteen years of her career, she worked as a pediatrician in private practice. In 2009 she transitioned to a specialty focus in weight management and eating disorders, creating a multidisciplinary team to evaluate, prevent, and treat these issues in a community practice setting. Dr. Rosen brought this…

Dr. Joaquin Fuster is a distinguished professor of Cognitive Neuroscience at UCLA's Semel Institute for Neuroscience and Human Behavior, renowned for his extensive research on the brain mechanisms underlying cognitive functions such as attention, perception, memory, and language. His groundbreaking contributions to the field have greatly advanced the understanding of cerebral cortex dysfunctions in neurological and mental illnesses, paving the way for more effective treatments and rehabilitation methods. With a prolific career spanning several decades, Dr. Fuster has developed innovative techniques for studying neurgenerative behavior in the brain, including the first microelectrode method for single neuron recording and the discovery of memory cells in the primate brain. He has authored pivotal works, including the influential "The Prefrontal Cortex," which consolidates his leading theories on executive functions vital for cognitive processes and behavioral organization. Generated from the website

Melissa G. Lechner, MD, PhD is an Assistant Professor of Medicine in the Division of Endocrinology, Diabetes, and Metabolism at the UCLA David Geffen School of Medicine. Her clinical and research interests are related to endocrine disease resulting from cancer immunotherapy (onco-endocrinology) and advanced thyroid cancer. She established the Onco-Endocrinology clinic at UCLA to care for patients with endocrine side effects from cancer immunotherapy and targeted therapies. She also has expertise in thyroid nodules (including biopsy).Dr. Lechner leads multiple prospective clinical trials at UCLA studying thyroid disease and cancer immunotherapy. She has received funding from the American Thyroid Association, Endocrine Fellows Foundation, and National Institutes of Health for her research and has been invited to speak nationally and internationally on the role of the immune system in cancer. She has published articles in Thyroid, The Journal of Clinical Endocrinology and Metabolism, The Journal of Immunology, Cancer, and Clinical Cancer Research, including original research and invited reviews, and serves on the National Comprehensive Cancer Network of Management of Immunotherapy Toxicity Side Effects guidance panel.After finishing her combined MD and PhD training in the joint USC Keck School of Medicine/Cal Tech physician-scientist training program, Dr. Lechner completed residencies in internal medicine and pediatrics at Brigham and Women's Hospital and Boston Children's Hospital of the Harvard Medical School. In 2018, she joined UCLA as a clinical fellow in endocrinology and post-doctoral researcher in the prestigious Specialty Training and Advanced Research (STAR) program. In 2020, Dr. Lechner joined the faculty at UCLA.